Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/1997

01-05-1997

Aspirin, but Not Sodium Salicylate, Indomethacin, or Nabumetone, Reversibly Suppresses 1,2-Dimethylhydrazine-Induced Colonic Aberrant Crypt Foci in Rats

Authors: Christopher J. Barnes, W. Elaine Hardman, Ivan L. Cameron, Makau Lee

Published in: Digestive Diseases and Sciences | Issue 5/1997

Login to get access
Metadata
Title
Aspirin, but Not Sodium Salicylate, Indomethacin, or Nabumetone, Reversibly Suppresses 1,2-Dimethylhydrazine-Induced Colonic Aberrant Crypt Foci in Rats
Authors
Christopher J. Barnes
W. Elaine Hardman
Ivan L. Cameron
Makau Lee
Publication date
01-05-1997
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 5/1997
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1018812430512

Other articles of this Issue 5/1997

Digestive Diseases and Sciences 5/1997 Go to the issue

OriginalPaper

Gastric Emptying in OLETF Rats Not Expressing CCK-A Receptor Gene

OriginalPaper

Case Report: Gastrospirillum hominis Gastritis in a Child with Celiac Sprue

OriginalPaper

Salivary Carbonic Anhydrase Protects Gastroesophageal Mucosa from Acid Injury

OriginalPaper

Adaptation of Esophageal Mucosa to Acid- and Pepsin-Induced Damage (Role of Nitric Oxide and Epidermal Growth Factor)

OriginalPaper

Case Report: Hypersensitivity to 5-ASA Suppositories

OriginalPaper

Effect of Pneumatic Dilation on Gastroesophageal Reflux in Achalasia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits